조직 진단 시장 규모, 점유율, 성장 분석 : 제품 유형별, 기술별, 질환 유형별, 검사법별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Tissue Diagnostics Market size was valued at USD 5.60 Billion in 2024 and is poised to grow from USD 6.07 Billion in 2025 to USD 11.57 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The global tissue diagnostics market is poised for significant growth, driven by the rising incidence of cancer and an evolving healthcare landscape. The pandemic temporarily hindered diagnostic testing due to resource reallocation, but as healthcare systems adapted, demand for precise diagnostic services surged. This resurgence highlights the urgent need for accurate monitoring of various diseases, particularly cancer. Furthermore, the convergence of anatomic and molecular pathology is reshaping the industry, with liquid biopsies becoming more prevalent. The increasing focus on computational pathology emphasizes the integration of bioinformatics and analytics, fostering innovation. Over two decades, advancements in sophisticated equipment have revolutionized the capabilities of pathologists and clinical practitioners, further propelling the expansion of the clinical pathology domain.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tissue Diagnostics Market Segments Analysis

Global Tissue Diagnostics Market is segmented by Product Type, Technology, Disease Type, Modality, End-user and region. Based on Product Type, the market is segmented into Consumables and Instruments. Based on Technology, the market is segmented into Immunohistochemistry, In Situ Hybridization, Primary & Special Staining, Anatomic Pathology, Molecular Pathology, Digital Pathology & Workflow Management and Special Staining. Based on Disease Type, the market is segmented into Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-small Cell Lung Cancer and Others. Based on Modality, the market is segmented into Clinical and Pharma / CRO / Research Market. Based on End-user, the market is segmented into Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations (CROs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tissue Diagnostics Market

A significant growth catalyst for the tissue diagnostics market is the rising incidence of chronic diseases, particularly cancer. As global cancer rates continue to escalate, the demand for swift and precise diagnostic solutions becomes crucial, as early detection is key to successful treatment outcomes. Innovations in tissue diagnostics, such as immunohistochemistry and molecular pathology, empower healthcare professionals to accurately identify tumor types and subtypes. The mounting need for reliable diagnostic tools is motivating healthcare providers to invest in advanced tissue diagnostic technologies. This trend not only propels market growth but also enhances the quality of care available to cancer patients.

Restraints in the Global Tissue Diagnostics Market

One significant challenge facing the Global Tissue Diagnostics market is the high cost associated with modern diagnostic techniques. Advanced tools and methodologies often come with substantial financial burdens, making them inaccessible for smaller hospitals and laboratories. The expenses related to equipment acquisition, staff training, and ongoing maintenance further exacerbate this issue, particularly in regions with limited healthcare resources. As a result, the high costs can hinder the adoption of innovative diagnostic solutions, especially in developing areas, which in turn restricts patient access to accurate diagnostic tools and ultimately stifles growth within the overall market for tissue diagnostics.

Market Trends of the Global Tissue Diagnostics Market

The Global Tissue Diagnostics market is experiencing a significant shift towards personalized healthcare, driven by the need for precision therapies that cater to individual patient profiles. This trend is bolstered by the increasing demand for advanced diagnostic tools capable of identifying specific biomarkers linked to various diseases and tumors. As medical professionals increasingly prioritize tailored treatment plans based on genetic and molecular insights, innovations in genetic profiling and molecular diagnostics are playing a crucial role in enabling these personalized approaches. Consequently, this focus on customized healthcare is fueling advancements in tissue diagnostics technology, paving the way for more effective and targeted therapeutic options for patients.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Tissue Diagnostics Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Consumables
  • Antibodies
  • Kits
  • Reagents
  • Probes
• Instruments
  • Slide-staining Systems
  • Scanners
  • Tissue-processing Systems
  • Other Instruments

Global Tissue Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Immunohistochemistry
• In Situ Hybridization
• Primary & Special Staining
• Anatomic Pathology
• Molecular Pathology
• Digital Pathology & Workflow Management
• Special Staining

Global Tissue Diagnostics Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Breast Cancer
• Gastric Cancer
• Lymphoma
• Prostate Cancer
• Non-small Cell Lung Cancer
• Others

Global Tissue Diagnostics Market Size by Modality & CAGR (2026-2033)

• Market Overview
• Clinical
• Pharma / CRO / Research Market

Global Tissue Diagnostics Market Size by End-user & CAGR (2026-2033)

• Market Overview
• Hospitals
• Research Laboratories
• Pharmaceutical Companies
• Contract Research Organizations (CROs)
• Others

Global Tissue Diagnostics Market Size & CAGR (2026-2033)

• North America (Product Type, Technology, Disease Type, Modality, End-user)
  • US
  • Canada
• Europe (Product Type, Technology, Disease Type, Modality, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Disease Type, Modality, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Disease Type, Modality, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Disease Type, Modality, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGenex Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio SB (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaGenic ASA (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujirebio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STRATEC SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Biosystems (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations